Synvivia
YC S16San Francisco, US · Delaware corporation · 4 employees · 3 known investors
Synvivia engineers molecules designed to reprogram cells. The company operates in the biotech sector.
AI & Machine LearningBiotechHealthtechArtificial IntelligenceSynthetic BiologyManufacturingDrug discoveryin /company@ycombinatorycombinator.com ↗
Founders & leadership· Y Combinator alumni (S16)
GL
Gabriel LopezinFounder/CEO
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$54.1KraisedDec 2023 · 1 investors · BiotechnologyRule 506(c)
▶$54.1KraisedDec 2023 · 1 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Gabriel LopezExecutive Officer, Director
- Offering amount
- $54.1K
- Amount sold
- $54.1K
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
